Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Product liability leqislation

Executive Summary

In comments on the Senate Commerce/Consumer Subcmte.'s draft bill, the Pharmaceutical Mfrs. Assn. stated that the proposed definition of an "unreasonably dangerous" product "can be read as requiring a mfr. to provide compensation by imputing to it knowledge that was in fact not capable of being known given the state of scientific and medical knowledge atthe time the product was sold." "The Pink Sheet" (Sept. 2, T&G-3) altered the quote by leaving out the word "not". N capable of being known given the state of scientific and medical knowledge atthe time the product was sold." "The Pink Sheet" (Sept. 2, T&G-3) altered the quote by leaving out the word "not".
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS008905

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel